| Literature DB >> 24040492 |
Charlotte Kühlbrandt1, Martin McKee.
Abstract
Light therapy is still used to treat a number of common diseases in Russia. The practice is firmly anchored in history: Soviet clinical practice was divorced from the emerging field of evidence-based medicine. Medical researchers were cut off from international medical research and scientific literature, with much Soviet scientific activity based on a particular socialist ideology. In this study, the use of light therapy serves as a case study to explore tensions between international evidence-based medicine and practices developed in isolation under the Soviet Union, the legacy of which is to the detriment of many patients today. We used four different search methods to uncover scientific and grey literature, both historical and contemporary. We assessed the changing frequency of publications over time and contrasted the volume of literature on light therapy with more orthodox treatments such as statins and painkillers. Our search found an increasing number and comparatively large body of scientific publications on light therapy in the Russian language, and many publications emanating from prestigious Russian institutions. Combined with our analysis of the historical literature and our appraisal of 22 full text articles, this leads us to suggest that light therapy entered mainstream Soviet medical practice before the Stalinist period and still occupies an important position in contemporary Russian clinical practice. We propose that this outdated treatment survives in Russia in part due to the political, economic and social forces that helped to popularize it during Soviet times, and by the seeming justification offered by poorly executed studies.Entities:
Year: 2013 PMID: 24040492 PMCID: PMC3767061 DOI: 10.1177/2042533313476697
Source DB: PubMed Journal: JRSM Short Rep ISSN: 2042-5333
Figure 1.Results for light therapy in scholar.google.ru 1991–2011 (fototerapiia/fototerapii; svetoterapiia/svetoterapii; svetolechenie/svetolecheniia in titles), accessed 19 November 2012.
Comparative search results for light therapy and other common treatments in Russian and English (column percentages), 1991–2012.
| Treatment | Pubmed | Google Scholar | Russkaia Meditsina | elibrary.ru | ||
|---|---|---|---|---|---|---|
| Russian | English | Russian | English | Russian | Russian | |
| Phototherapy | 27 (15%) | 1232 (7%) | 204 (50%) | 2820 (7%) | 163 (23%) | 102 (13%) |
| Light therapy | 0 (0%) | 327 (2%) | 8 (2%) | 872 (2%) | 39 (6%) | 26 (3%) |
| Atorvastatin | 35 (19%) | 2457 (13%) | 35 (9%) | 5820 (14%) | 100 (14%) | 133 (17%) |
| Simvastatin | 31 (17% | 2746 (15%) | 20 (5%) | 6440 (15%) | 87 (12%) | 112 (14%) |
| Aspirin | 63 (34%) | 7671 (41%) | 105 (26%) | 15300 (36%) | 221 (31%) | 218 (28%) |
| Paracetamol | 27 (15%) | 1992 (11%) | 22 (5%) | 6080 (14%) | 61 (9%) | 109 (14%) |
| Ibuprofen | 3 (2%) | 2285 (12%) | 14 (3%) | 5630 (13%) | 33 (5%) | 84 (11%) |
Note: Accessed 19 November 2012.
Illustrative examples of study designs.
|
|
|
| Phototherapy of haemorheological disorders in coronary failure, comparing standard treatment with 254 nm and 436 nm wavelength light therapy. | Rating the effect of phototherapy on ‘psychoautonomic disorders of neurological nature’ and to work out indications and contraindications for light therapy. |
|
|
|
| Thirty-four patients were non-randomly allocated to three groups. Patients were recruited from an in-patient facility and presented with CHD, angina, diffuse cardio, atherosclerosis of the aorta and its branches, all of whom had elevated ‘blood viscosity’ levels (and concomitant diseases: 30 hypertensive heart disease; 10 obesity; eight chronic ischemia of the brain with stroke; five chronic bronchitis with pneumosclerosis; six diabetes; five chronic pancreatitis; four chronic pyelonephritis). | Fifty-one patients with ‘psychoautonomic disorders’, 33 women; 18 men; average age 35 received light therapy (1 h bright light therapy daily for two weeks, 60 cm from lamp, 3300 lux). Sixteen patients received placebo therapy (1 h bright light, 3 m from lamp at 500 lux). The control group consisted of 10 healthy subjects. Clinical-neurological studies were conducted on them. Forty-three outcomes were measured, including neuro-endocrine, motivation, psychoautonomic, pain, psychopathologic, EEG spectrum, urine excretion of metabolites of catecholamines and serotonin. |
| 1. Control group: | |
| 2. Treatment A: | |
| 3. Treatment B: | |
| Blood viscosity measured as ‘viscosity of whole blood and plasma, haematocrit and fibrinogen concentrations’, using the Swiss-made machine: ‘Low Shear’. | |
|
|
|
| Results show that baseline levels of blood viscosity were elevated in comparison to the ‘norm’ in all three groups ( | ‘Improvement occurred in 52% of the patients (responders – group 1, nonresponders – group 2). Changes occurred in nearly all symptoms: neuroendocrine, motivation, psychoautonomic, pain, psychopathologic. After the treatment in group 1 there was an increase of power of EEG spectrum, intensification of manifestations of the slow activity and decrease of the fast one from the two sides, an approach of the coefficient of asymmetry to the control levels as well as elevation of the urine excretion of metabolites of both catecholamines and serotonin. Initially higher power of EEG spectrum in group 2 became still more increased due to intensification of manifestations of theta and beta-2 rhythms from the two sides. Meanwhile coefficient of asymmetry was sharply decreased as well as general secretory activity inhibited. There were such symptoms and indices which had changed either negatively or positively under the influence of phototherapy’ (quoted from the English abstract). |
|
|
|
| ‘Only blue light phototherapy produced a positive effect on blood viscosity due, primarily, to haematocrit reduction.’ | ‘[…] Phototherapy has a positive effect on the brain function […]’ |